Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Defining Optimal Imaging Strategies for Diagnosis, Treatment, and Treatment Evaluation of Chordomas and Chondrosarcomas of the Axial Skeleton

NCT04832620 is registered in ClinicalTrials.gov with Leiden University Medical Center as lead sponsor.

NCT NCT04832620
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04832620 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Defining Optimal Imaging Strategies for Diagnosis, Treatment, and Treatment Evaluation of Chordomas and Chondrosarcomas of the Axial Skeleton
Lead sponsor
Leiden University Medical Center
Phase
Observational
Overall status
Recruiting
Start date
February 2, 2021
Completion date
December 31, 2027
Enrollment
40 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

bone neoplasm of vertebral column, chondrosarcoma, chordoma, magnetic resonance imaging, pet-ct, proton therapy